PT768892E - Composicao trombolitica - Google Patents
Composicao tromboliticaInfo
- Publication number
- PT768892E PT768892E PT95924413T PT95924413T PT768892E PT 768892 E PT768892 E PT 768892E PT 95924413 T PT95924413 T PT 95924413T PT 95924413 T PT95924413 T PT 95924413T PT 768892 E PT768892 E PT 768892E
- Authority
- PT
- Portugal
- Prior art keywords
- pct
- native
- sec
- trombolitic
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/484—Plasmin (3.4.21.7)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21068—Tissue plasminogen activator (3.4.21.68), i.e. tPA
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9412131A GB9412131D0 (en) | 1994-06-17 | 1994-06-17 | Thrombolytic composition |
Publications (1)
Publication Number | Publication Date |
---|---|
PT768892E true PT768892E (pt) | 2004-04-30 |
Family
ID=10756864
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT95924413T PT768892E (pt) | 1994-06-17 | 1995-06-14 | Composicao trombolitica |
Country Status (10)
Country | Link |
---|---|
US (1) | US5741771A (pt) |
EP (1) | EP0768892B1 (pt) |
JP (1) | JP3690803B2 (pt) |
AT (1) | ATE253937T1 (pt) |
DE (1) | DE69532123T2 (pt) |
DK (1) | DK0768892T3 (pt) |
ES (1) | ES2210298T3 (pt) |
GB (1) | GB9412131D0 (pt) |
PT (1) | PT768892E (pt) |
WO (1) | WO1995035117A1 (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7264809B1 (en) * | 1998-10-16 | 2007-09-04 | Immunex Corporation | Methods of inhibiting platelet activation and recruitment |
US6797820B2 (en) * | 1999-12-17 | 2004-09-28 | Vicuron Pharmaceuticals Inc. | Succinate compounds, compositions and methods of use and preparation |
DE10153601A1 (de) * | 2001-11-02 | 2003-05-22 | Paion Gmbh | DSPA zur Behandlung von Schlaganfall |
US20080057050A1 (en) * | 2003-05-02 | 2008-03-06 | Paion Deutschland Gmbh | Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke |
US20060135425A1 (en) * | 2003-05-02 | 2006-06-22 | Paion Deutschland Gmbh | Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke |
TWI482628B (zh) * | 2007-10-18 | 2015-05-01 | Lundbeck & Co As H | 新穎之血栓溶解病患次群 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2764264B2 (ja) * | 1987-10-01 | 1998-06-11 | 株式会社ミドリ十字 | 線溶活性増強剤 |
US5087572A (en) * | 1989-12-01 | 1992-02-11 | Genentech, Inc. | Dna encoding human plasminogen modified at the cleavage site |
GB8927722D0 (en) * | 1989-12-07 | 1990-02-07 | British Bio Technology | Proteins and nucleic acids |
US5688664A (en) * | 1990-12-07 | 1997-11-18 | British Bio-Technology Ltd. | Thrombin activatable plasminogen analogues |
GB9222758D0 (en) * | 1992-10-29 | 1992-12-09 | British Bio Technology | Proteins and nucleic acids |
WO1994001128A1 (en) * | 1992-07-01 | 1994-01-20 | Beth Israel Hospital Boston | Enhancement of thrombolytic therapy with deglycosylated plasminogen |
GB9216558D0 (en) * | 1992-08-04 | 1992-09-16 | British Bio Technology | Modified proteases |
DK125693D0 (pt) * | 1993-11-05 | 1993-11-05 | Novo Nordisk As |
-
1994
- 1994-06-17 GB GB9412131A patent/GB9412131D0/en active Pending
-
1995
- 1995-06-14 US US08/750,711 patent/US5741771A/en not_active Expired - Fee Related
- 1995-06-14 PT PT95924413T patent/PT768892E/pt unknown
- 1995-06-14 ES ES95924413T patent/ES2210298T3/es not_active Expired - Lifetime
- 1995-06-14 DK DK95924413T patent/DK0768892T3/da active
- 1995-06-14 DE DE69532123T patent/DE69532123T2/de not_active Expired - Fee Related
- 1995-06-14 AT AT95924413T patent/ATE253937T1/de not_active IP Right Cessation
- 1995-06-14 EP EP95924413A patent/EP0768892B1/en not_active Expired - Lifetime
- 1995-06-14 WO PCT/GB1995/001388 patent/WO1995035117A1/en active IP Right Grant
- 1995-06-14 JP JP50180796A patent/JP3690803B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US5741771A (en) | 1998-04-21 |
DK0768892T3 (da) | 2004-03-15 |
ES2210298T3 (es) | 2004-07-01 |
DE69532123T2 (de) | 2004-08-26 |
JPH10501548A (ja) | 1998-02-10 |
WO1995035117A1 (en) | 1995-12-28 |
JP3690803B2 (ja) | 2005-08-31 |
ATE253937T1 (de) | 2003-11-15 |
EP0768892A1 (en) | 1997-04-23 |
EP0768892B1 (en) | 2003-11-12 |
GB9412131D0 (en) | 1994-08-10 |
DE69532123D1 (de) | 2003-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0719154T3 (da) | Aktiveret faktor VIII som terapeutisk middel og metode til behandling af faktor VIII-mangel | |
IL205695A0 (en) | Compositions containing dspa alpha 1 for the treatment of stroke | |
DE60139078D1 (de) | Plasminogen aktivator zur verhinderung von horn- und subepithelialeintrübung nach laser-sehkraftkorrektur-chirurgie | |
CY1107995T1 (el) | ΑΝΑΣΤΟΛΗ ΔΡΑΣΤΙΚΟΤΗΤΑΣ p38 ΚΙΝΑΣΗΣ ΧΡΗΣΙΜΟΠΟΙΩΝΤΑΣ ΑΡΥΛ ΚΑΙ ΕΤEPΟΑΡΥΛ ΥΠΟΚΑΤΕΣΤΗΜΕΝΕΣ ΕΤEPΟΚΥΚΛΙΚΕΣ ΟΥΡΙΕΣ | |
LU92255I2 (fr) | Ocriplasmine et ses dérivés pharmaceutiquement acceptables (JETREA) | |
FI951856A0 (fi) | Farmaseuttinen koostumus osteoporoosin hoitamiseksi | |
PT768892E (pt) | Composicao trombolitica | |
DE69120287D1 (en) | Aminosulfonylharnstoff-acat-inhibitoren | |
YU49422B (sh) | Upotreba inhibitora ugljenične anhidraze za proizvodnju medikamenata za tretiranje makularnog edema ili makularne degeneracije izazvane starošću | |
ATE179164T1 (de) | Hiv-proteaseinhibitoren | |
DK2359853T3 (da) | Farmaceutiske sammensætninger og fremgangsmåder, der er anvendelige til at modulere antiogenese | |
LV11272A (lv) | Terapeitiska kompozicija | |
AU4502589A (en) | Thrombolytic agents with modified kringle domains | |
ATE103178T1 (de) | T-pa pro stabilisierung. | |
ATE171213T1 (de) | Plasminogen-derivate die durch thrombin aktivierbar sind | |
ATE80308T1 (de) | Thrombotische zusammensetzungen. |